If you think you have CHS or cannabis use disorder, talk to a healthcare provider. One study found that 32.9% of self-reported frequent marijuana users who came to an emergency department for care met the criteria for CHS. With the widespread use, increased potency and legalization of marijuana in multiple states in the U.S., CHS may be becoming increasingly common. Cannabinoid hyperemesis syndrome (CHS) can affect people who use cannabis (marijuana) long-term. One surefire sign of the illness is when patients find relief in hot showers and baths.

History

• However, in the digestive tract, marijuana has the opposite effect and makes nausea and vomiting more likely to occur.
• The patient reported that he got the rash from prolonged exposure to hot water in showers that he took to relieve the symptoms of his CHS 143.
• People with a cannabis addiction may need additional help to make this happen.

Of this patient population, 32.9% (95% confidence interval, range 24.5–40.3%) were considered to have met criteria for CHS (chronic cannabis use, episodes of sometimes severe nausea and vomiting, symptomatic relief from hot showers) 72. If these results are applied to the general population of regular marijuana users in the US, it is possible that 2.75 million Americans (range 2.13–3.38 million) suffer from CHS 72. It is likely many are not even aware that their symptoms relate to their cannabinoid use.

Differential Diagnosis

However, there are numerous cases of people with the condition being hospitalized for weeks. The emotional and physical toll of CHS has been devastating to some, as many sufferers were misdiagnosed and made many visits to the emergency room as a result. The doctor decided that Brian needed to be at a children’s hospital to receive specialized care. They agreed with the CHS diagnosis and ordered monitoring of his levels, which improved with the rehydration again. His levels slowly improved overnight, and he was released after 24 hours. Brian agreed to quit smoking until he was able to see a gastroenterologist, which was scheduled for 45 days after his release.

• Other pharmacological interventions, such as droperidol used in the ED for the treatment of CHS, showed accelerated discharge which may help preserve ED resources 27, 28.
• During stress or food deprivation the body breaks down fat and a large reservoir of stored delta (9)-tetrahydrocannabinol is released causing a “reintoxification effect” 25.

Cannabis and psychosis

Cutaneous problems arise typically from prolonged and excessive exposure to very hot water, heating pads, or hot water bottles. Gastric motility and gastroparesis must be discussed in the context of CHS. The enteric nervous system contains CB1 receptors, which, when activated, can inhibit GI motility by inhibiting the release of those transmitters that cause stomach contractions 47. This effect causes delayed gastric emptying and continues to inhibit transit through the small intestine. The effects are similar to gastroparesis and, thus, CHS may be caused by a functional gastroparesis.

This applies not just to botanical marijuana; dronabinol (delta-9-tetrahydrocannabinol) slows gastric emptying and decreases colonic tone as well 54. For patients with cancer, drug-drug interactions between chemotherapy agents may contribute to nausea and vomiting, which was possibly observed in the patient's case. The interaction between nabilone and her other medications could lead to undesirable adverse events. Cisplatin and paclitaxel could increase the paclitaxel level by reducing drug clearance through the kidneys, resulting in delayed metabolism of nabilone and leading to toxicity, manifested by CHS 26. Nabilone undergoes extensive first pass how long does it take to recover from cannabinoid hyperemesis syndrome clearance, with active metabolites persisting greater than 20 h 27. Additionally, nabilone elimination occurs in the feces (65%) rather than the urine (20%) 27, suggesting that reduced urine clearance by paclitaxel is unlikely, however, cannot be completely ruled out in this case.

Case Report:

This concern is particularly pronounced in individuals already experiencing sequelae of recreational drug use, necessitating careful patient selection and monitoring when considering benzodiazepines as part of CHS management 43. In addition to the supportive measures mentioned above, certain pharmacological treatments have shown promise in alleviating symptoms. Haloperidol, a dopamine antagonist and antipsychotic often used off-label as an anti-emetic 36, has demonstrated effectiveness in halting intractable vomiting in CHS patients, with symptom cessation reported as early as https://ecosoberhouse.com/ one hour after administration 37. Capsaicin, applied to the abdomen, has shown success in resolving symptoms in all 15 CHS patients studied in one case report and two case series 38-40.

3 CHS, pesticides and neem oil

What most people don’t realize, researchers say, is that the THC young people are vaping and dabbing today has little resemblance to the marijuana of decades past. Commercial sales skyrocketed in Canada, as did the choice of cannabis products on the market. His death came as a shock to his mother six months after his diagnosis.

Data Availability Statement

When these receptors are activated, they can influence mood and behavior, and in some individuals, may contribute to adverse psychological effects such as depression and suicidal ideation. This raises important concerns about the safety profile of future cannabinoid-based medications and therapies. As research progresses, careful consideration will be needed to balance therapeutic benefits with the potential for harmful side effects, particularly for vulnerable populations. The modulation of CB1 receptors holds promise but also necessitates further investigation to ensure the safety and well-being of patients undergoing such treatments 44-46.

The association did not comment on amphetamine addiction treatment public health concerns related to high-THC products sold legally in Washington state, which are at the heart of regulation efforts. But those advocates are fighting a multibillion-dollar cannabis industry resistant to any form of regulation and a public largely convinced marijuana is harmless. There is also a belief that marijuana may help in opioid addiction recovery, and researchers are publishing new studies all the time, highlighting many other potential benefits.